The "Expert Consensus on the Clinical Management of Retinopathy of Prematurity (ROP) 2024," developed by the Chinese Medical Association's Neonatology Subspecialty Group, provides guidelines for preventing and managing ROP in preterm infants in China. It highlights the importance of managing oxygen therapy, nutrition, anemia, and other risk factors. Key recommendations include controlling oxygen saturation, optimizing nutrition for weight gain, preventing anemia, and addressing infections and inflammation. The consensus aims to assist healthcare professionals in reducing ROP incidence and associated vision loss and is registered with the international practice guideline platform (PREPARE-2024CN893).